J.P. Rowan

687 total citations
10 papers, 142 citations indexed

About

J.P. Rowan is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, J.P. Rowan has authored 10 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Reproductive Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in J.P. Rowan's work include Endometriosis Research and Treatment (4 papers), Estrogen and related hormone effects (3 papers) and Menopause: Health Impacts and Treatments (3 papers). J.P. Rowan is often cited by papers focused on Endometriosis Research and Treatment (4 papers), Estrogen and related hormone effects (3 papers) and Menopause: Health Impacts and Treatments (3 papers). J.P. Rowan collaborates with scholars based in United States and Poland. J.P. Rowan's co-authors include James P. Symons, Leon Speroff, W. H. Wilborn, Matti Korhonen, Herman Ellman, James A. Simon, Ernst J. Schaefer, Stefania Lamon‐Fava, Donald D. Cilla and Donald M. Black and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Fertility and Sterility and Atherosclerosis.

In The Last Decade

J.P. Rowan

10 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.P. Rowan United States	5	68	62	58	56	28	10	142
Purdey J. Campbell Australia	4	31 0.5×	43 0.7×	42 0.7×	8 0.1×	4 0.1×	10	120
FZ Stanczyk United States	5	38 0.6×	24 0.4×	37 0.6×	4 0.1×	8 0.3×	9	113
Piret Kelgo Estonia	5	22 0.3×	40 0.6×	56 1.0×	6 0.1×	4 0.1×	5	124
Dimitrios Zouzoulas Greece	6	19 0.3×	5 0.1×	33 0.6×	31 0.6×	5 0.2×	22	83
K. Machens Germany	2	18 0.3×	15 0.2×	11 0.2×	9 0.2×	6 0.2×	3	39
F. Clavel-Chapelon France	3	24 0.4×	22 0.4×	15 0.3×	8 0.1×	10 0.4×	3	70
Chang Hai Tsai Taiwan	6	11 0.2×	24 0.4×	17 0.3×	10 0.2×	7 0.3×	8	77
Rajesh Rawal Germany	3	26 0.4×	29 0.5×	13 0.2×	2 0.0×	16 0.6×	3	78
Sakshi Gera United States	7	31 0.5×	14 0.2×	11 0.2×	2 0.0×	7 0.3×	12	114
Antonio Rico Cano Spain	3	58 0.9×	41 0.7×	16 0.3×	3 0.1×	13 0.5×	6	75

Countries citing papers authored by J.P. Rowan

Since Specialization

Citations

This map shows the geographic impact of J.P. Rowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Rowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Rowan more than expected).

Fields of papers citing papers by J.P. Rowan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Rowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Rowan. The network helps show where J.P. Rowan may publish in the future.

Co-authorship network of co-authors of J.P. Rowan

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Rowan. A scholar is included among the top collaborators of J.P. Rowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Rowan. J.P. Rowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Taylor, Hugh S., Linda C. Giudice, Bruce A. Lessey, et al.. (2016). Elagolix, an oral gonadotropin-releasing hormone antagonist, for the management of endometriosis-associated pain: safety and efficacy results from two double-blind, randomized, placebo-controlled studies. Fertility and Sterility. 106(3). e271–e271. 3 indexed citations

Taylor, Hugh S., Eric S. Surrey, Ahmed M. Soliman, et al.. (2016). The impact of elagolix on quality of life in women with endometriosis-associated pain: results from two randomized, placebo-controlled studies using the endometriosis health profile questionnaire. Fertility and Sterility. 106(3). e93–e93. 1 indexed citations

Diamond, Michael P., James A. Simon, Bruce A. Lessey, et al.. (2016). The effect of elagolix on the endometrium: safety results from two randomized, placebo-controlled studies in women with endometriosis-associated pain. Fertility and Sterility. 106(3). e94–e95. 2 indexed citations

Giudice, Linda C., Bruce A. Lessey, Laura Williams, et al.. (2016). Use of elagolix for the management of endometriosis-associated pain: secondary efficacy results from two randomized, placebo-controlled studies. Fertility and Sterility. 106(3). e268–e269. 3 indexed citations

Rowan, J.P., James A. Simon, Leon Speroff, & Herman Ellman. (2006). Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 μg) in women with postmenopausal symptoms: Updated analysis of three randomized, controlled trials. Clinical Therapeutics. 28(6). 921–932. 19 indexed citations

Speroff, Leon, et al.. (2000). The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt??) on the frequency and intensity of vasomotor symptoms. Menopause The Journal of The North American Menopause Society. 7(6). 383–390. 38 indexed citations

Rowan, J.P.. (1999). “Estrophasic” dosing: A new concept in oral contraceptive therapy. American Journal of Obstetrics and Gynecology. 180(2). S302–S306. 7 indexed citations

Korhonen, Matti, et al.. (1997). Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). American Journal of Obstetrics and Gynecology. 176(2). 377–380. 53 indexed citations

Speroff, Leon, J.P. Rowan, James P. Symons, Harry K. Genant, & Walter H. Wilborn. (1997). The Comparative Effect on Bone Density, Endometrium, and Lipids of Continuous Hormones as Replacement Therapy (CHART Study). Obstetrical & Gynecological Survey. 52(4). 240–242. 4 indexed citations

10.

Schaefer, Ernst J., Stefania Lamon‐Fava, Thomas Cole, et al.. (1996). Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels. Atherosclerosis. 127(1). 113–122. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact